Filing Details

Accession Number:
0001144204-13-005998
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-05 11:58:50
Reporting Period:
2013-02-05
Filing Date:
2013-02-05
Accepted Time:
2013-02-05 11:58:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1424812 Amarantus Bioscience Inc. AMBS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1566928 Gerald Commissiong 675 Almanor Avenue
Sunnyvale CA 94085
Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-11 10,000 $0.07 7,502,300 No 5 P Direct
Common Stock Acquisiton 2013-01-11 15,000 $0.07 7,517,300 No 5 P Direct
Common Stock Acquisiton 2013-01-11 10,000 $0.09 7,527,300 No 5 P Direct
Common Stock Acquisiton 2013-01-14 15,000 $0.09 7,542,300 No 5 P Direct
Common Stock Acquisiton 2013-02-05 47,900 $0.08 7,590,200 No 5 P Direct
Common Stock Acquisiton 2013-02-05 2,100 $0.08 7,592,300 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Commonstock Common Stock Options Acquisiton 2011-05-04 269,329 $0.03 269,329 $0.03
Commonstock 5% Convertible Preferred Stock Acquisiton 2012-07-15 471,250 $0.00 23,562,500 $1.50
Commonstock 5% Convertible Preferred Stock Acquisiton 2012-11-04 500,000 $0.00 25,000,000 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
269,329 No 4 A Direct
23,531,829 No 4 A Direct
48,531,829 No 4 A Direct
Footnotes
  1. No specific date set.
  2. Set based upon current price, actual price will be determined on the date of conversion.
  3. N/A